Readystate Asset Management LP Gilead Sciences, Inc. Call Options Transaction History

Readystate Asset Management LP

  • $3.08 Trillion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 10, 2024
SELL
$71.58 - $87.29 $1.58 Million - $1.93 Million
-22,100 Reduced 51.76%
20,600 $1.51 Billion
Q4 2023

Feb 14, 2024
BUY
$73.27 - $83.09 $2.91 Million - $3.3 Million
39,700 Added 1323.33%
42,700 $3.46 Billion
Q2 2023

Aug 14, 2023
SELL
$76.01 - $86.7 $76,010 - $86,700
-1,000 Reduced 25.0%
3,000 $231 Million
Q1 2023

May 15, 2023
BUY
$77.31 - $88.08 $309,240 - $352,320
4,000 New
4,000 $332 Million

Others Institutions Holding GILD

# of Institutions
1,879
Shares Held
1.02B
Call Options Held
12M
Put Options Held
8.96M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $104B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email